{"name":"Ractigen Therapeutics.","slug":"ractigen-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxPT3NlSTdFSDhpc3U4MWNBN2xsUDVWeC03TVZha3Q4LWo5RDJyLWk4VDU3a19UX1NyU1p4WnJwOGEwTEVDTnZQSEIzcHdoVW92X2p3bnNJOGZuRTdodUgzcVUydWgxOWg2VWtHaVhMUEZSYVY1U3JJRXJjVkNHM3REZmhwdjBfVTJrazVwYVhoLWJja1lUUzNiZDlBbmY4YkhOVzdkRTRKdzRYVXk4TmRRMkNEVnVjVU5kcEtsZDhvNA?oc=5","date":"2026-01-15","type":"trial","source":"BioPharma APAC","summary":"Ractigen Doses First Patient In Phase Two Trial Of RAG 17 For SOD1 Mutated Als - BioPharma APAC","headline":"Ractigen Doses First Patient In Phase Two Trial Of RAG 17 For SOD1 Mutated Als","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxNVVg1MG1EY1JJTVVMQVNRbkVWaE5FejNfWnAwYkE3VHVCcFF6V0ZIZ2taTUNCZjZodkkyTXpmRmV4TTk5MTREbUp1dTl4RUFhVG5xalBfSDRoTEtBMndWbDlFNHI4ZkNUUXBodXVLZFNKQ0xnSXlZcVEweV9wZk1aSGd4OC1uZmp6WGRmaWd0eUxVQm5lUXUtX0ZYVjBlYTZJdG04clBVZFFQS3dwQk9Rd05LWEU3dFo1U08xcmxB?oc=5","date":"2025-03-25","type":"trial","source":"Clinical Trials Arena","summary":"Ractigen’s RAG-01 shows potential in treating non-muscle invasive bladder cancer - Clinical Trials Arena","headline":"Ractigen’s RAG-01 shows potential in treating non-muscle invasive bladder cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTE9OODhPV09ManIzSWJzN05jSEVuN002RjdUYThENEE3RVpZNWJLWFF3SHhwa2t5b0hYZldfMC1wT2Y4QVd0YlFvd09wNHVLZDFJRF83VzFGeGNwU005dnI3LVF3T2MwNGN5eFRVc0Jwa2JvNmZjY1E?oc=5","date":"2024-12-26","type":"trial","source":"Clinical Trials Arena","summary":"Ractigen doses first subject in Phase I ALS treatment trial - Clinical Trials Arena","headline":"Ractigen doses first subject in Phase I ALS treatment trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxORVFEdVh2b3ZPNnhVVlU0Z0xzdlpnOTZCbi1ZSUFhM2lWMnoya1IySEtiRVB0Tl9UV3ozQ3M5T0pRZ0xjRnpCR1RjYUt4ekd0YW5OT29YcjAxM3FObF9fRmZfMWstc2lLdkNsNi1ZVkQ1aHlMWFZnTThNQmpYcmVQQzhscTZXcFBLRnZuQWxjR0M2WDVfMlBjWnRXcG1zSGlyREZzYzV4VWFOS1NGSEpaOWQ1ck9vRUVQaWhSRFZGQ0YyS1BfMkVPTlhpX3NtS0Frd0tOdEhxTWNOSHlpNUVJVWd2SWNJQzZiTU9VQg?oc=5","date":"2024-10-16","type":"pipeline","source":"GlobeNewswire","summary":"80+ Pharma Companies Unite to Shape the Future of RNA-Based Therapeutics | DelveInsight - GlobeNewswire","headline":"80+ Pharma Companies Unite to Shape the Future of RNA-Based Therapeutics | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxQNjVrMDNzQVhBVDhaSHV3UTJpN3A0S2ZRZnBEcVBfNzhGVS1ZYVhHUXdnREhwS2FSaC1oMlRoWWZuOWtQT0xOUy1CTTlsa0VDb2xpS2FPTzdVRUtVTTcteDUwWDZzZDdyenlKbjdjbmtqUlJqOWw2S2gxYU5OTTJjbHNfVlV3ZmFZWXhlaVhCWmJ4MEJzOGtlNWJnYjctb1AzempiMUgwR3Z2bTczanlfTENMeEQ3dVBRRllEdjhmWnJqZmFvalU4aFpn?oc=5","date":"2024-09-11","type":"trial","source":"BioPharma APAC","summary":"Ractigen Therapeutics Reports Positive Clinical Data from ALS-SOD1 Trial of RAG-17 - BioPharma APAC","headline":"Ractigen Therapeutics Reports Positive Clinical Data from ALS-SOD1 Trial of RAG-17","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxNVDZIbWE2cTNYUXZ2cTNZSFM0ek9YcGRVQWdqMHZobTMzc0pIX2UySTZTRzdkWjlCQ2Zod190NXIyVnRsTzE2Mjl2NmNtTHlUeFgwanRuUGFuWGdpaFdCQnJOd3BESzVTY2tQMm01SEhlQ0ZEdG1DcHZyNWthRTFlS0UyZXZ5MXZSVjRIeDZtS0Q2N042SURjMm50Z0hvaE93czhpUC1sakZKNXpnX042WHRBZ0RzdkNIa1pmRTNtVURDSmVuangzMFJWdDhMSm9xTDRESWhzZ29kMVVRYUJYQXM3dTdsNXNCeGFIcQ?oc=5","date":"2024-07-26","type":"regulatory","source":"BioPharma APAC","summary":"Ractigen Therapeutics' RAG-18 Receives FDA Rare Pediatric Disease Designation for Duchenne Muscular Dystrophy - BioPharma APAC","headline":"Ractigen Therapeutics' RAG-18 Receives FDA Rare Pediatric Disease Designation for Duchenne Muscular Dystrophy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxQaFdKRXdwbzhkTTlIN2xvNjhZTG9ib2JtSTZ2UjhsRmREQmRSamZCck90NTc3WDY1MkdkZ19xWlJxLTdGX1pUdm9vVnJGQlMyOTljZDNSY0pleDJxWTloY0ZoVUprMWgzU0FyUWxoOUVMdEhiZUcyXzBSYnhqcUtwTVZwZ2dkQ195OWowa29fM1lZZjkwbWlReHg0aw?oc=5","date":"2024-07-04","type":"pipeline","source":"KrASIA","summary":"China’s pharmaceutical industry bets big on small nucleic acid drugs in 2024 - KrASIA","headline":"China’s pharmaceutical industry bets big on small nucleic acid drugs in 2024","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxNVDRzelJNdmJIai1LUldsVGtCa3ZCeVJ2Tl9OdEh1a08wdnhSRVZQYzhUNzFlblVJNGVBckxzcEZWQjN6LTJvWVE5MWNfanQ1aXRLWXltdTJsRHB6TjJRcTJURWVxc1l5Ym8wdWVadXlTREljcHRYZGc0bldDMnVYQV9JbjBtZw?oc=5","date":"2024-04-29","type":"regulatory","source":"Pharmaceutical Business review -","summary":"FDA approves Ractigen Therapeutics’ RAG-01 IND for bladder cancer - Pharmaceutical Business review -","headline":"FDA approves Ractigen Therapeutics’ RAG-01 IND for bladder cancer - Pharmaceutical Business review -","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMickFVX3lxTE1NSldnczlncnM0bS1xUVdQTDdTUmFxX2JBaHJKQmlzTjV4R080SmxCdWhFTHlxVWpRS2hBcHJOVElXNjhNRWRKRGlGZ0RuTFpOVVEwVVlKTFF5c2FtdnVSem51V0FSVmotVDNha3pVaEFxZw?oc=5","date":"2024-04-10","type":"trial","source":"Oncology Pipeline","summary":"Familiar targets with a twist | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline","headline":"Familiar targets with a twist | ApexOnco - Clinical Trials news and analysis","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}